Closing price as of 2026-06-12 · Source: TEK2day Finance
1-Year Price History-23.1% over period
Key Metrics
Market Cap
$988,373.00
About Protagenic Therapeutics, Inc.new
Protagenic Therapeutics, Inc. operates as a pharmaceutical company specializing in the development of medicines manufactured from cannabinoid and cannabinoid-like molecules. Protagenic Therapeutics, Inc. was founded in 2004 and is based in Santa Barbara, California.
Want live quotes, estimates, SEC filings, and CEO analytics for PTIX? The free TEK2day terminal runs in your browser — type /PTIX to get started.